Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Hits Forecast Price Target with 20.28% Profit

May 03, 2023
ELI LILLY AND COMPANY (LLY) stock has successfully reached the forecast price target set by QuantWave, resulting in a profit of 20.28%. The forecast signal was given on December 20, 2022, at a price of 352.49 $. The predicted direction was long, and on May 3, 2023, the stock reached a price of 423.98 $. This achievement highlights the accuracy and effectiveness of QuantWave's analytics in predicting stock movements.

The market analysis indicates that ELI LILLY AND COMPANY has shown strong performance over the forecast period, possibly driven by positive developments in the pharmaceutical industry and the company's own strategic initiatives. Factors such as successful drug launches, revenue growth, and market expansion may have contributed to the stock's upward movement.

QuantWave's ability to accurately forecast the price target for ELI LILLY AND COMPANY demonstrates the platform's reliability in providing valuable insights for investors. By leveraging QuantWave's automated forecasting system, users have the opportunity to access predictions for a wide range of stocks, enabling them to potentially capitalize on profitable opportunities.

For investors interested in understanding more about QuantWave's investment strategy, QuantSchool offers comprehensive educational resources. QuantSchool presents the fundamental principles for generating consistent income through the QuantWave forecasting system, empowering individuals to make informed investment decisions.

Find out how the ELI LILLY AND COMPANY rate is expected to change

Get Forecast for LLY
There are no comments yet. Be the first to leave a comment
If you want to leave a comment, then you need Login or Register





Other news for LLY

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....



Related news

REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits QuantWave's Price Target Forecast with a Profit of 17.34%  ~1 min.

On January 23, 2025, QuantWave, the automated forecasting platform, issued a short forecast signal for REGENERON PHARMACEUTICALS, INC. stock when it was trading at 692.73 $....

VRTXJune 4, 2024VERTEX PHARMACEUTICALS Stock Hits Forecasted Price Target with 14.32% Profit: QuantWave Analysis  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED has successfully reached the price target forecasted by QuantWave, resulting in a profitable outcome for investors....

PFEDecember 14, 2022PFIZER INC. Hits Price Target Forecast with 9.65% Profit: A Success Story for QuantWave  ~1 min.

In a significant milestone for QuantWave, the automated forecasting platform successfully predicted a long signal for PFIZER INC. on August 12, 2022, when the stock was trading at 43.24 $....

REGNAugust 15, 2024REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 19.37% Profit: QuantWave Analysis  ~1 min.

REGENERON PHARMACEUTICALS, INC. has achieved the price target forecast set by QuantWave, resulting in a profit of 19.37%....

REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.89% Profit  ~1 min.

QuantWave's forecast for REGENERON PHARMACEUTICALS, INC. proved accurate as the stock reached the predicted target price on April 4, 2025....